Historical record - last NADAC effective date: 2/1/2021
Product Information
QUDEXY XR 50 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $11.1338 per EA under NDC 00245107230. Its NADAC has been published 179 times since Oct 17, 2018.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245107230
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/1/2021
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for QUDEXY XR 50 MG CAPSULE has been published 179 times since Oct 17, 2018, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1338 per EA |
|---|---|
| All-time high | $11.1338 (Mar 16, 2022) |
| All-time low | $9.3617 (Oct 17, 2018) |
| Median price | $10.5493 |
| Average price | $10.4743 |
| Largest weekly change | +6.0% (Feb 3, 2021) |
| Weeks tracked | 179 |
| Tracking since | Oct 17, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
+18.9%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUDEXY XR 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 50 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $11.1338 per EA (NDC 00245107230), effective Mar 16, 2022.
How has the price of QUDEXY XR 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUDEXY XR 50 MG CAPSULE has risen 18.9%. It has been tracked across 179 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for QUDEXY XR 50 MG CAPSULE?
Since Oct 17, 2018, the NADAC for QUDEXY XR 50 MG CAPSULE has ranged from a low of $9.3617 (Oct 17, 2018) to a high of $11.1338 (Mar 16, 2022), with a median of $10.5493 per EA.
Are there cheaper alternatives to QUDEXY XR 50 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 50 MG SPRINKL CAP, is $3.3778 per EA — about 70% below QUDEXY XR 50 MG CAPSULE.
Who manufactures QUDEXY XR 50 MG CAPSULE?
QUDEXY XR 50 MG CAPSULE (NDC 00245107230) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.